rs1927350
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001846.4(COL4A2):c.2038+137T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.577 in 988,302 control chromosomes in the GnomAD database, including 170,331 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.60 ( 27927 hom., cov: 33)
Exomes 𝑓: 0.57 ( 142404 hom. )
Consequence
COL4A2
NM_001846.4 intron
NM_001846.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.997
Publications
3 publications found
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]
COL4A2 Gene-Disease associations (from GenCC):
- porencephaly 2Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- COL4A1 or COL4A2-related cerebral small vessel diseaseInheritance: AD Classification: MODERATE Submitted by: Illumina
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 13-110466199-T-G is Benign according to our data. Variant chr13-110466199-T-G is described in ClinVar as Benign. ClinVar VariationId is 1273943.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.703 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL4A2 | NM_001846.4 | c.2038+137T>G | intron_variant | Intron 26 of 47 | ENST00000360467.7 | NP_001837.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.596 AC: 90568AN: 152028Hom.: 27894 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
90568
AN:
152028
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.574 AC: 479656AN: 836156Hom.: 142404 AF XY: 0.571 AC XY: 238722AN XY: 417812 show subpopulations
GnomAD4 exome
AF:
AC:
479656
AN:
836156
Hom.:
AF XY:
AC XY:
238722
AN XY:
417812
show subpopulations
African (AFR)
AF:
AC:
14510
AN:
20120
American (AMR)
AF:
AC:
10261
AN:
23648
Ashkenazi Jewish (ASJ)
AF:
AC:
10494
AN:
16174
East Asian (EAS)
AF:
AC:
8139
AN:
32462
South Asian (SAS)
AF:
AC:
23219
AN:
48902
European-Finnish (FIN)
AF:
AC:
18873
AN:
42634
Middle Eastern (MID)
AF:
AC:
2973
AN:
4346
European-Non Finnish (NFE)
AF:
AC:
368998
AN:
609626
Other (OTH)
AF:
AC:
22189
AN:
38244
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
9430
18859
28289
37718
47148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8572
17144
25716
34288
42860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.596 AC: 90660AN: 152146Hom.: 27927 Cov.: 33 AF XY: 0.583 AC XY: 43368AN XY: 74372 show subpopulations
GnomAD4 genome
AF:
AC:
90660
AN:
152146
Hom.:
Cov.:
33
AF XY:
AC XY:
43368
AN XY:
74372
show subpopulations
African (AFR)
AF:
AC:
29443
AN:
41508
American (AMR)
AF:
AC:
7670
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
2328
AN:
3472
East Asian (EAS)
AF:
AC:
1520
AN:
5170
South Asian (SAS)
AF:
AC:
2224
AN:
4824
European-Finnish (FIN)
AF:
AC:
4534
AN:
10582
Middle Eastern (MID)
AF:
AC:
215
AN:
294
European-Non Finnish (NFE)
AF:
AC:
40846
AN:
67986
Other (OTH)
AF:
AC:
1265
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1836
3672
5508
7344
9180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
744
1488
2232
2976
3720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1409
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.